PharmaCyte Biotech Inc (PMCB)
2.44
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 15:09
PharmaCyte Biotech Shareholders Equity (Quarterly): 48.89M for Jan. 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 48.89M |
October 31, 2023 | 58.07M |
July 31, 2023 | 59.48M |
April 30, 2023 | 72.69M |
January 31, 2023 | 77.12M |
October 31, 2022 | 81.04M |
July 31, 2022 | 86.30M |
April 30, 2022 | 89.92M |
January 31, 2022 | 91.33M |
October 31, 2021 | 92.12M |
July 31, 2021 | 5.712M |
April 30, 2021 | 6.680M |
January 31, 2021 | 7.613M |
October 31, 2020 | 8.277M |
July 31, 2020 | 6.245M |
April 30, 2020 | 5.089M |
January 31, 2020 | 4.319M |
October 31, 2019 | 4.534M |
July 31, 2019 | 5.000M |
April 30, 2019 | 5.040M |
January 31, 2019 | 5.366M |
October 31, 2018 | 5.404M |
July 31, 2018 | 6.198M |
April 30, 2018 | 5.769M |
January 31, 2018 | 5.838M |
Date | Value |
---|---|
October 31, 2017 | 7.348M |
July 31, 2017 | 8.659M |
April 30, 2017 | 8.087M |
January 31, 2017 | 7.037M |
October 31, 2016 | 6.283M |
July 31, 2016 | 7.067M |
April 30, 2016 | 6.523M |
January 31, 2016 | 6.936M |
October 31, 2015 | 6.562M |
July 31, 2015 | 6.956M |
April 30, 2015 | 7.777M |
January 31, 2015 | 6.248M |
October 31, 2014 | 6.382M |
July 31, 2014 | 7.827M |
April 30, 2014 | 8.942M |
January 31, 2014 | 5.183M |
October 31, 2013 | 3.603M |
July 31, 2013 | 2.40M |
April 30, 2013 | -0.9215M |
January 31, 2013 | -1.449M |
October 31, 2012 | -2.054M |
July 31, 2012 | -2.373M |
April 30, 2012 | -1.700M |
January 31, 2012 | -2.248M |
October 31, 2011 | -2.376M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.319M
Minimum
Jan 2020
92.12M
Maximum
Oct 2021
40.77M
Average
28.59M
Median
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 12.65M |
AIM ImmunoTech Inc | 22.60M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 7.037M |
Protalix BioTherapeutics Inc | 33.57M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 71.36M |
Total Liabilities (Quarterly) | 22.47M |